MICROVISION, INC.

Previous wording

For the six months ended June 30, 2026, $0.6 million, or 25%, of total revenue was derived from Iris sensor sales to a leading global manufacturer of construction and mining equipment, $0.5 million, or 22%, of total revenue was derived from Movia L sensors sales to an EU-based robotics company delivering autonomy systems in the Security & Defense sector, and $0.5 million, or 21%, was derived from a top-ten global automotive OEM customer. For the same period in 2025, a leading manufacturer of agricultural equipment and an automotive supplier accounted for $0.5 million and $0.2 million of total revenue, respectively, representing 66% and 22% of total revenue, respectively. Our revenue has been negatively affected by the loss of certain of these customers and could continue to be if not retained or replaced with new, materially equivalent customer wins.

Current wording

For the nine months ended September 30, 2026, 31% and 20% of total revenue was derived from two customers in the Security & Defense sector, respectively, 15% was derived from an industrial customer, and 10% was derived from an automotive manufacturer. For the same period in 2025, an industrial customer, an automotive supplier, and an automotive manufacturer accounted for 51%, 20%, and 18% of total revenue, respectively. Our revenue has been negatively affected by the loss of certain of these customers and could continue to be if not retained or replaced with new, materially equivalent customer wins.

Previous wording

Our stock price has fluctuated significantly in the past, has recently been volatile, and may be volatile in the future. Adjusting for the 1-for-15 reverse stock split that became effective on August 1, 2026, over the 52-week period ending August 3, 2026, our common stock has traded at a low of $3.45 and a high of $23.10. We may continue to experience sustained depression or substantial volatility in our stock price in the foreseeable future unrelated to our operating performance or prospects. For the six months ended June 30, 2026, we incurred a loss per share of $2.90 (as adjusted to reflect the 1-for-15 reverse stock split).

Current wording

Our stock price has fluctuated significantly in the past, has recently been volatile, and may be volatile in the future. Adjusting for the 1-for-15 reverse stock split that became effective on August 1, 2026, over the 52-week period ending October 21, 2026, our common stock has traded at a low of $1.08 and a high of $18.75. We may continue to experience sustained depression or substantial volatility in our stock price in the foreseeable future unrelated to our operating performance or prospects. For the nine months ended September 30, 2026, we incurred a loss per share of $3.18 (as adjusted to reflect the 1-for-15 reverse stock split).

Previous wording

Our common stock is listed on The Nasdaq Stock Market, which requires that we meet Nasdaq’s continued listing requirements. On January 12, 2026, we received a notification letter from Nasdaq advising that, based upon the closing bid price for the last 30 consecutive business days, the Company no longer met the continued listing requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5450(a)(1), and granted the Company 180 days to regain compliance. Prior to the July 13, 2026 compliance deadline, Nasdaq approved our application to transfer our listing from The Global Market to The Capital Market, which was effective July 20, 2026, and determined that the Company was eligible for an additional 180-day compliance period. On August 1, 2026, a 1-for-15 reverse stock split became effective, as approved by our Board of Directors on July 21 st and by our shareholders at our 2026 Annual Meeting of Shareholders on July 10 th. To regain compliance with the minimum bid price requirement, our common stock must have a closing price of $1 or more for ten consecutive trading days at some point prior to the January 11, 2027 compliance deadline. We can provide no assurance that this will be achieved.

Current wording

Our common stock is listed on The Nasdaq Stock Market, which requires that we meet Nasdaq’s continued listing requirements. On January 12, 2026, we received a notification letter from Nasdaq advising that, based upon the closing bid price for the last 30 consecutive business days, the Company no longer met the continued listing requirement to maintain a minimum bid price of $1 per share, as set forth in Nasdaq Listing Rule 5450(a)(1), and granted the Company 180 days to regain compliance. Prior to the July 13, 2026 compliance deadline, Nasdaq approved our application to transfer our listing from The Global Market to The Capital Market, which was effective July 20, 2026, and determined that the Company was eligible for an additional 180-day compliance period. On August 1, 2026, a 1-for-15 reverse stock split became effective, as approved by our Board of Directors on July 21 st and by our shareholders at our 2026 Annual Meeting of Shareholders on July 10 th. On August 26, 2026, we received notice from Nasdaq advising that the Company had regained compliance.

Previous wording

As a result of severe declines and volatility in our stock price, there is a significant risk that we could fail to regain compliance with the minimum bid price requirement. If, for any reason, we are unable to regain compliance within the 180-day period and also continue to meet Nasdaq’s listing maintenance standards, such as our minimum bid price falling below $1 for 30 consecutive trading days, our common stock could be delisted from The Nasdaq Stock Market. If our common stock were delisted, we may seek to list our common stock on the NYSE American or on a regional stock exchange or, if one or more broker-dealer market makers comply with applicable requirements, the over-the-counter, or OTC, market. Listing on such other market or exchange could reduce the liquidity of our common stock. If our common stock were to trade in the OTC market, an investor would find it more difficult to dispose of, or to obtain accurate quotations for the price of, the common stock.

Current wording

As a result of severe declines and volatility in our stock price, there is a significant risk that our stock price could again fall below the $1 minimum bid price requirement for 30 consecutive trading days. In this event, we would expect to receive a notice of noncompliance from Nasdaq and it is uncertain whether Nasdaq would grant a grace period to regain compliance. Accordingly, there is risk that, in the event of noncompliance and an unfavorable Nasdaq position, our common stock could be delisted from The Nasdaq Stock Market. If our common stock were delisted, we may seek to list our common stock on the NYSE American or on a regional stock exchange or, if one or more broker-dealer market makers comply with applicable requirements, the over-the-counter, or OTC, market. Listing on such other market or exchange could reduce the liquidity of our common stock. If our common stock were to trade in the OTC market, an investor would find it more difficult to dispose of, or to obtain accurate quotations for the price of, the common stock.

Previous wording

On August 3, 2026, the closing price of our common stock was $3.85 per share .

Current wording

On October 21, 2026, the closing price of our common stock was $1.20 per share.

Previous wording

In 2021, we established an office in Germany and on January 31, 2023, we completed our acquisition of certain assets of Ibeo, with the result that we now have more employees and operations in Germany than in the U.S. In addition, we currently use foreign suppliers and partners and plan to continue to do so to manufacture current and future components and products, where appropriate. These international operations are subject to inherent risks, which may adversely affect us, including, but not limited to:

Current wording

In 2021, we established an office in Germany and on January 31, 2023, we completed our acquisition of certain assets of Ibeo, with the result that we now have a significant portion of our employees and operations outside of the U.S. In addition, we currently use foreign suppliers and partners and plan to continue to do so to manufacture current and future components and products, where appropriate. These international operations are subject to inherent risks, which may adversely affect us, including, but not limited to: